Yiheng Capital Management, L.P. Inventiva S.A. Put Options Transaction History
Yiheng Capital Management, L.P.
- $1.02 Billion
- Q1 2025
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding IVA
# of Institutions
8Shares Held
4.87MCall Options Held
0Put Options Held
0-
Nea Management Company, LLC Timonium, MD1.46MShares$4.67 Million0.41% of portfolio
-
Bvf Inc San Francisco, CA686KShares$2.19 Million0.09% of portfolio
-
Commonwealth Equity Services, LLC54.5KShares$173,8100.0% of portfolio
-
Wealth Enhancement Advisory Services, LLC16.6KShares$52,8200.0% of portfolio
-
Ubs Group Ag708Shares$2,2580.0% of portfolio
About Inventiva S.A.
- Ticker IVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,134,200
- Market Cap $134M
- Description
- Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company als...